These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8618630)

  • 21. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
    Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
    J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterococci: susceptibility patterns and therapeutic options.
    Nicoletti G; Stefani S
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S33-7. PubMed ID: 7729470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enterococcal urinary tract infections: eight years experience at a regional hospital in Trinidad, West Indies.
    Orrett FA; Connors E
    Chin Med J (Engl); 2001 Jan; 114(1):90-2. PubMed ID: 11779446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin-resistant enterococci: mechanisms and clinical observations.
    Gold HS
    Clin Infect Dis; 2001 Jul; 33(2):210-9. PubMed ID: 11418881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation.
    Christidou A; Gikas A; Scoulica E; Pediaditis J; Roumbelaki M; Georgiladakis A; Tselentis Y
    Clin Microbiol Infect; 2004 Nov; 10(11):999-1005. PubMed ID: 15522003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emergence of enterococci as a cause of nosocomial infection.
    Hunt CP
    Br J Biomed Sci; 1998 Jun; 55(2):149-56. PubMed ID: 10198473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enterococci: acquired antibiotic resistance].
    Alonso T; Pérez JL; Liñares J
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):489-96. PubMed ID: 1489779
    [No Abstract]   [Full Text] [Related]  

  • 31. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey.
    Cirak MY; Sultan N
    Acta Microbiol Pol; 1998; 47(3):267-73. PubMed ID: 9990710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging vancomycin resistance in enterococci in India.
    Ghoshal U; Garg A; Tiwari DP; Ayyagari A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of antibiotic-resistant Gram-positive pathogens.
    Lode HM
    Clin Microbiol Infect; 2009 Mar; 15(3):212-7. PubMed ID: 19335368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan.
    Chiang PC; Wu TL; Su JY; Huang YC; Chiu YP; Chia JH; Kuo AJ; Su LH
    Chang Gung Med J; 2007; 30(6):493-503. PubMed ID: 18350732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of glycopeptide-resistant enterococci in transplant medicine internal wards in 2001-2005.
    Młynarczyk G; Grzybowska W; Młynarczyk A; Tyski S; Kawecki D; Łuczak M; Durlik M; Paczek L; Chmura A; Rowiński W
    Transplant Proc; 2007 Nov; 39(9):2886-9. PubMed ID: 18022009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
    Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
    J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.
    Jones RN; Sader HS; Erwin ME; Anderson SC
    Diagn Microbiol Infect Dis; 1995 Feb; 21(2):85-93. PubMed ID: 7628198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-resistant enterococci at a large university hospital in Denmark.
    Kjerulf A; Pallesen L; Westh H
    APMIS; 1996 Jun; 104(6):475-9. PubMed ID: 8774678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination therapy against vancomycin-resistant enterococci].
    Kariyama R; Kumon H
    Nihon Rinsho; 2001 Apr; 59(4):733-8. PubMed ID: 11304998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.